Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia--results of th...
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia--results of the AMLSG 11-08 trial
About this item
Full title
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia--results of the AMLSG 11-08 trial
Author / Creator
Publisher
Nature Publishing Group
Journal title
Leukemia, 2018, Vol.32 (7), p.1621
Language
English
Formats
Publication information
Publisher
Nature Publishing Group
Subjects
More information
Alternative Titles
Full title
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia--results of the AMLSG 11-08 trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A572678465
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A572678465
Other Identifiers
ISSN
0887-6924
DOI
10.1038/s41375-018-0129-6
How to access this item
Log in as a Library member